Latigo Biotherapeutics Inc.
NASDAQ:LTGOMedical - Pharmaceuticals
+$0.76 today
- Market cap
- $800.64M
- Beta
- 0.00
Volume 0.21M
Average 0.38M
Price history
Latigo Biotherapeutics Inc. SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-27.07%
Period high
$25.00
Period low
$12.60
Latest
$13.31
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| SC 13G | Nov 13, 2026 | Nov 13, 2026 | |
| SC 13G/A | Nov 6, 2026 | Nov 6, 2026 | |
| 10-Q | Nov 5, 2026 | Nov 5, 2026 | |
| 8-K | Nov 5, 2026 | Nov 5, 2026 | |
| SC 13G | Oct 29, 2026 | Oct 29, 2026 | |
| 10-Q | Sep 3, 2026 | Sep 3, 2026 | |
| 8-K | Sep 3, 2026 | Sep 3, 2026 | |
| SC 13G | Aug 18, 2026 | Aug 18, 2026 | |
| SC 13D | Aug 17, 2026 | Aug 17, 2026 | |
| SC 13G | Aug 17, 2026 | Aug 17, 2026 | |
| SC 13G | Aug 13, 2026 | Aug 13, 2026 | |
| 4 | Aug 12, 2026 | Aug 12, 2026 | |
| 4 | Aug 12, 2026 | Aug 12, 2026 | |
| 3 | Aug 12, 2026 | Aug 12, 2026 | |
| 4 | Aug 11, 2026 | Aug 11, 2026 |
Competitors
Who does Latigo Biotherapeutics Inc. compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
Questions
Filing questions
Common questions about LTGO's filings, answered from its disclosures.
What is the latest LTGO filing?
The latest filing shown is SC 13G dated Nov 13, 2026.
How many recent filings does LTGO have?
Intrinsic Alpha currently shows 20 recent filings for LTGO.
Continue the stock analysis
Jump to another research area for this company.